196 related articles for article (PubMed ID: 29155103)
1. RASGRP1 mutation in autoimmune lymphoproliferative syndrome-like disease.
Mao H; Yang W; Latour S; Yang J; Winter S; Zheng J; Ni K; Lv M; Liu C; Huang H; Chan KW; Pui-Wah Lee P; Tu W; Fischer A; Lau YL
J Allergy Clin Immunol; 2018 Aug; 142(2):595-604.e16. PubMed ID: 29155103
[TBL] [Abstract][Full Text] [Related]
2. Novel Mutations in RASGRP1 are Associated with Immunodeficiency, Immune Dysregulation, and EBV-Induced Lymphoma.
Somekh I; Marquardt B; Liu Y; Rohlfs M; Hollizeck S; Karakukcu M; Unal E; Yilmaz E; Patiroglu T; Cansever M; Frizinsky S; Vishnvenska-Dai V; Rechavi E; Stauber T; Simon AJ; Lev A; Klein C; Kotlarz D; Somech R
J Clin Immunol; 2018 Aug; 38(6):699-710. PubMed ID: 30030704
[TBL] [Abstract][Full Text] [Related]
3. Decreased activation-induced cell death by EBV-transformed B-cells from a patient with autoimmune lymphoproliferative syndrome caused by a novel FASLG mutation.
Ruiz-García R; Mora S; Lozano-Sánchez G; Martínez-Lostao L; Paz-Artal E; Ruiz-Contreras J; Anel A; González-Granado LI; Moreno-Pérez D; Allende LM
Pediatr Res; 2015 Dec; 78(6):603-8. PubMed ID: 26334989
[TBL] [Abstract][Full Text] [Related]
4. RASGRP1 deficiency causes immunodeficiency with impaired cytoskeletal dynamics.
Salzer E; Cagdas D; Hons M; Mace EM; Garncarz W; Petronczki ÖY; Platzer R; Pfajfer L; Bilic I; Ban SA; Willmann KL; Mukherjee M; Supper V; Hsu HT; Banerjee PP; Sinha P; McClanahan F; Zlabinger GJ; Pickl WF; Gribben JG; Stockinger H; Bennett KL; Huppa JB; Dupré L; Sanal Ö; Jäger U; Sixt M; Tezcan I; Orange JS; Boztug K
Nat Immunol; 2016 Dec; 17(12):1352-1360. PubMed ID: 27776107
[TBL] [Abstract][Full Text] [Related]
5. Clinical, immunological, and genetic features in 780 patients with autoimmune lymphoproliferative syndrome (ALPS) and ALPS-like diseases: A systematic review.
Hafezi N; Zaki-Dizaji M; Nirouei M; Asadi G; Sharifinejad N; Jamee M; Erfan Rasouli S; Hamedifar H; Sabzevari A; Chavoshzadeh Z; Yazdani R; Abolhassani H; Aghamohammadi A; Azizi G
Pediatr Allergy Immunol; 2021 Oct; 32(7):1519-1532. PubMed ID: 33963613
[TBL] [Abstract][Full Text] [Related]
6. Next Generation Sequencing for Detecting Somatic
López-Nevado M; Docampo-Cordeiro J; Ramos JT; Rodríguez-Pena R; Gil-López C; Sánchez-Ramón S; Gil-Herrera J; Díaz-Madroñero MJ; Delgado-Martín MA; Morales-Pérez P; Paz-Artal E; Magerus A; Rieux-Laucat F; Allende LM
Front Immunol; 2021; 12():656356. PubMed ID: 33995372
[TBL] [Abstract][Full Text] [Related]
7. EBV Negative Lymphoma and Autoimmune Lymphoproliferative Syndrome Like Phenotype Extend the Clinical Spectrum of Primary Immunodeficiency Caused by STK4 Deficiency.
Schipp C; Schlütermann D; Hönscheid A; Nabhani S; Höll J; Oommen PT; Ginzel S; Fleckenstein B; Stork B; Borkhardt A; Stepensky P; Fischer U
Front Immunol; 2018; 9():2400. PubMed ID: 30386345
[TBL] [Abstract][Full Text] [Related]
8. Advances in autoimmune lymphoproliferative syndromes.
Madkaikar M; Mhatre S; Gupta M; Ghosh K
Eur J Haematol; 2011 Jul; 87(1):1-9. PubMed ID: 21447005
[TBL] [Abstract][Full Text] [Related]
9. Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management.
López-Nevado M; González-Granado LI; Ruiz-García R; Pleguezuelo D; Cabrera-Marante O; Salmón N; Blanco-Lobo P; Domínguez-Pinilla N; Rodríguez-Pena R; Sebastián E; Cruz-Rojo J; Olbrich P; Ruiz-Contreras J; Paz-Artal E; Neth O; Allende LM
Front Immunol; 2021; 12():671755. PubMed ID: 34447369
[TBL] [Abstract][Full Text] [Related]
10. A novel homozygous Fas ligand mutation leads to early protein truncation, abrogation of death receptor and reverse signaling and a severe form of the autoimmune lymphoproliferative syndrome.
Nabhani S; Hönscheid A; Oommen PT; Fleckenstein B; Schaper J; Kuhlen M; Laws HJ; Borkhardt A; Fischer U
Clin Immunol; 2014 Dec; 155(2):231-7. PubMed ID: 25451160
[TBL] [Abstract][Full Text] [Related]
11. A Spectrum of Clinical Findings from ALPS to CVID: Several Novel LRBA Defects.
Cagdas D; Halaçlı SO; Tan Ç; Lo B; Çetinkaya PG; Esenboğa S; Karaatmaca B; Matthews H; Balcı-Hayta B; Arıkoğlu T; Ezgü F; Aladağ E; Saltık-Temizel İN; Demir H; Kuşkonmaz B; Okur V; Gümrük F; Göker H; Çetinkaya D; Boztuğ K; Lenardo M; Sanal Ö; Tezcan İ
J Clin Immunol; 2019 Oct; 39(7):726-738. PubMed ID: 31432443
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune lymphoproliferative syndrome: an update and review of the literature.
Shah S; Wu E; Rao VK; Tarrant TK
Curr Allergy Asthma Rep; 2014 Sep; 14(9):462. PubMed ID: 25086580
[TBL] [Abstract][Full Text] [Related]
13. A novel homozygous mutation in RASGRP1 that predisposes to immune dysregulation and immunodeficiency associated with uncontrolled Epstein-Barr virus-induced B cell proliferation.
Mansour R; El-Orfali Y; Saidu A; Al-Kalamouni H; Mardirossian H; Hanna-Wakim R; Abboud M; Massaad MJ
Clin Immunol; 2023 Dec; 257():109813. PubMed ID: 37898412
[TBL] [Abstract][Full Text] [Related]
14. Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
Sneller MC; Wang J; Dale JK; Strober W; Middelton LA; Choi Y; Fleisher TA; Lim MS; Jaffe ES; Puck JM; Lenardo MJ; Straus SE
Blood; 1997 Feb; 89(4):1341-8. PubMed ID: 9028957
[TBL] [Abstract][Full Text] [Related]
15. Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS).
Teachey DT; Seif AE; Grupp SA
Br J Haematol; 2010 Jan; 148(2):205-16. PubMed ID: 19930184
[TBL] [Abstract][Full Text] [Related]
16. FAS-mediated apoptosis impairment in patients with ALPS/ALPS-like phenotype carrying variants on CASP10 gene.
Miano M; Cappelli E; Pezzulla A; Venè R; Grossi A; Terranova P; Palmisani E; Maggiore R; Guardo D; Lanza T; Calvillo M; Micalizzi C; Pierri F; Vernarecci C; Beccaria A; Corsolini F; Lanciotti M; Russo G; Ceccherini I; Dufour C; Fioredda F
Br J Haematol; 2019 Nov; 187(4):502-508. PubMed ID: 31309545
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune Lymphoproliferative Syndrome in Children with Nonmalignant Organomegaly, Chronic Immune Cytopenia, and Newly Diagnosed Lymphoma.
Kaya Z; Işık M; Oruklu N; Kirkiz S; Bağrıaçık EÜ; Allende LM; Díaz-Madroñero MJ; Ruiz-García R; Pınarlı FG; Göçün Uyar P; Koçak Ü
Turk J Haematol; 2021 Jun; 38(2):145-150. PubMed ID: 33375216
[TBL] [Abstract][Full Text] [Related]
18. Loss of RASGRP1 in humans impairs T-cell expansion leading to Epstein-Barr virus susceptibility.
Winter S; Martin E; Boutboul D; Lenoir C; Boudjemaa S; Petit A; Picard C; Fischer A; Leverger G; Latour S
EMBO Mol Med; 2018 Feb; 10(2):188-199. PubMed ID: 29282224
[TBL] [Abstract][Full Text] [Related]
19. T and B cell clonal expansion in Ras-associated lymphoproliferative disease (RALD) as revealed by next-generation sequencing.
Levy-Mendelovich S; Lev A; Rechavi E; Barel O; Golan H; Bielorai B; Neumann Y; Simon AJ; Somech R
Clin Exp Immunol; 2017 Sep; 189(3):310-317. PubMed ID: 28500641
[TBL] [Abstract][Full Text] [Related]
20. Chronic immunodeficiency in mice lacking RasGRP1 results in CD4 T cell immune activation and exhaustion.
Priatel JJ; Chen X; Zenewicz LA; Shen H; Harder KW; Horwitz MS; Teh HS
J Immunol; 2007 Aug; 179(4):2143-52. PubMed ID: 17675473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]